Vicept Pipeline

Vicept focuses on creating products for use in the largest and fastest growing sectors of the dermatology market. The company expects to develop its first product, V-101, as a stand-alone, prescription topical formulation for the treatment of the erythema of rosacea, as currently no effective topical therapy for erythema exists. Additionally, we are pursuing indications which include the treatment and prevention of a number of dermatologic conditions including actinic (solar) purpura and peri-procedural bruising of the skin.

Rosacea
Rosacea is a common, chronic condition of the skin that is estimated to affect over 16 million people in the United States and over 45 million people worldwide.
Read More

Actinic Purpura
Actinic Purpura ('solar' or 'Bateman's' Purpura), a condition of easy bruising of the skin in chronically sun-exposed areas (usually the forearms, back of the hands, legs), is a significant cosmetic concern for many older adults.
Read More